2799 |
Optimal DAPT Duration for Current and Future DES and BVS |
Roxana Mehran |
Apr. 21. 16 |
2798 |
Incidence and Predictors of Recurrent Restenosis After DEB for DES-ISR: A Patient-Level Pooled Analysis from 4 RCT |
Bo Xu |
Apr. 21. 16 |
2797 |
Updated Data of DEB 2016 |
Imad Sheiban |
Apr. 21. 16 |
2796 |
Very Long-Term Follow-up (>10 Years) After PCI and CABG |
Takeshi Kimura |
Apr. 21. 16 |
2795 |
Prognostic Value of FFR: Insight from IRIS-FFR Registry |
Jung-Min Ahn |
Apr. 21. 16 |
2794 |
Understanding About Low Post Stenting FFR |
Joon-Hyung Doh |
Apr. 21. 16 |
2793 |
Next DES: What Are Changing for Stent Platforms of Drug, Polymer or Strut |
Stephen G. Ellis |
Apr. 21. 16 |
2792 |
Practical Aspect of IMR in AMI and Stable Angina |
Jung-Min Ahn |
Apr. 21. 16 |
2791 |
The BioFreedom Drug Coated Stent: 2016 Update Stents - Drug-Eluting |
Philip M. Urban |
Apr. 21. 16 |
2790 |
Low FFR But Normal Thallium: How to Evaluate, Interpret and Treat It? |
Soo-Jin Kang |
Apr. 21. 16 |